 |
Also known as: Cerubidine
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Daunorubicin.
No reviews have yet been submitted. Be the first to review this drug.
The chemotherapy used to treat a form of adult leukemia sets a trap that can result in the return of the disease within years, a new study suggests. The...
- Results Presented in Oral Session at the American Society of Hematology Annual Meeting - Encouraging Survival Rates in Secondary AML Provides Rationale...
- Phase 2 Monotherapy Study Enrollment Complete - - Phase 1 Study in Combination with Chemotherapy Initiated - SAN DIEGO, Dec. 13, 2011...
CPX-351 demonstrated significant survival benefit in first relapse acute myeloid leukemia patients with unfavorable prognostic scores -- -- Improvements...
Data to be presented at 53rd Annual American Society of Hematology Meeting (ASH) SAN DIEGO, Dec. 12, 2011 /PRNewswire/ -- Cornerstone Pharmaceuticals today...
Looking for answers? Ask a question or go join the daunorubicin support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
